Search Results - "THOMPSON, Bruce W"

Familial aggregation of sarcoidosis: A case-control etiologic study of sarcoidosis (ACCESS) by RYBICKI, Benjamin A, IANNUZZI, Michael C, DEPALO, Louis, HUNNINGHAKE, Gary, JOHNS, Carol, JUDSON, Marc A, KNATTERUD, Genell L, MCLENNAN, Geoffrey, NEWMAN, Lee S, RABIN, David L, ROSE, Cecile, TEIRSTEIN, Alvin S, FREDERICK, Margaret M, WEINBERGER, Steven E, YEAGER, Henry, CHERNIACK, Reuben, THOMPSON, Bruce W, ROSSMAN, Milton D, BRESNITZ, Eddy A, TERRIN, Michael L, MOLLER, David R, BARNARD, Juliana, BAUGHMAN, Robert P

“…Despite reports of familial clustering of sarcoidosis, little empirical evidence exists that disease risk in family members of sarcoidosis cases is greater…”
Get full text

The diagnostic pathway to sarcoidosis by Judson, Marc A, Thompson, Bruce W, Rabin, David L, Steimel, Joanne, Knattereud, Genell L, Lackland, Daniel T, Rose, Cecile, Rand, Cynthia S, Baughman, Robert P, Teirstein, Alvin S

“…To examine the time from the first physician visit to the diagnosis of sarcoidosis. The time required to diagnose sarcoidosis is dependent on the initial…”
Get more information

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) by Wang, Winfred C, Prof, Ware, Russell E, Prof, Miller, Scott T, Prof, Iyer, Rathi V, Prof, Casella, James F, Prof, Minniti, Caterina P, MD, Rana, Sohail, Prof, Thornburg, Courtney D, MD, Rogers, Zora R, Prof, Kalpatthi, Ram V, MD, Barredo, Julio C, Prof, Brown, R Clark, MD, Sarnaik, Sharada A, Prof, Howard, Thomas H, Prof, Wynn, Lynn W, MSN, Kutlar, Abdullah, Prof, Armstrong, F Daniel, Prof, Files, Beatrice A, MD, Goldsmith, Jonathan C, MD, Waclawiw, Myron A, PhD, Huang, Xiangke, MD, Thompson, Bruce W, PhD

“…Summary Background Sickle-cell anaemia is associated with substantial morbidity from acute complications and organ dysfunction beginning in the first year of…”
Get full text

Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes by Sheehan, Vivien A., Luo, Zhaoyu, Flanagan, Jonathan M., Howard, Thad A., Thompson, Bruce W., Wang, Winfred C., Kutlar, Abdullah, Ware, Russell E.

“…The recently completed BABY HUG trial investigated the safety and efficacy of hydroxyurea in infants with sickle cell anemia (SCA). To investigate the effects…”
Get full text

Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort by Leader, Joseph K, Crothers, Kristina, Huang, Laurence, King, Mark A, Morris, Alison, Thompson, Bruce W, Flores, Sonia C, Drummond, Michael B, Rom, William N, Diaz, Philip T

“…INTRODUCTION:The disease spectrum for HIV-infected individuals has shifted toward comorbid non-AIDS conditions including chronic lung disease, but quantitative…”
Get full text

Hydroxyurea Is Associated With Lower Costs of Care of Young Children With Sickle Cell Anemia by WANG, Winfred C, OYEKU, Suzette O, ZHAOYU LUO, BOULET, Sheree L, MILLER, Scott T, CASELLA, James F, FISH, Billie, THOMPSON, Bruce W, GROSSE, Scott D

“…In the BABY HUG trial, young children with sickle cell anemia randomized to receive hydroxyurea had fewer episodes of pain, hospitalization, and transfusions…”
Get full text

Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial by Rogers, Zora R., Wang, Winfred C., Luo, Zhaoyu, Iyer, Rathi V., Shalaby-Rana, Eglal, Dertinger, Stephen D., Shulkin, Barry L., Miller, John H., Files, Bea, Lane, Peter A., Thompson, Bruce W., Miller, Scott T., Ware, Russell E.

“…We evaluated spleen function in 193 children with sickle cell anemia 8 to 18 months of age by 99mTc sulfur-colloid liver-spleen scan and correlated results…”
Get full text

A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors by Newman, Lee S, Rose, Cecile S, Bresnitz, Eddy A, Rossman, Milton D, Barnard, Juliana, Frederick, Margaret, Terrin, Michael L, Weinberger, Steven E, Moller, David R, McLennan, Geoffrey, Hunninghake, Gary, DePalo, Louis, Baughman, Robert P, Iannuzzi, Michael C, Judson, Marc A, Knatterud, Genell L, Thompson, Bruce W, Teirstein, Alvin S, Yeager, Henry, Jr, Johns, Carol J, Rabin, David L, Rybicki, Benjamin A, Cherniack, Reuben, ACCESS Research Group

“…Past research suggests that environmental factors may be associated with sarcoidosis risk. We conducted a case control study to test a priori hypotheses that…”
Get full text

Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: Results from the BABY-HUG phase III clinical trial by McGann, Patrick T., Flanagan, Jonathan M., Howard, Thad A., Dertinger, Stephen D., He, Jin, Kulharya, Anita S., Thompson, Bruce W., Ware, Russell E.

“…Background The laboratory and clinical benefits of hydroxyurea therapy for children with sickle cell anemia (SCA) are well recognized, but treatment in young…”
Get full text

Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection by Foster, Samuel B, Lu, Ming, Glaze, Daniel G, Reuben, James M, Harris, Lynnette L, Cohen, Evan N, Lee, Bang-Ning, Zhao, Enxu, Paul, Mary E, Schwarzwald, Heidi, McMullen-Jackson, Chivon, Clark, Charla, Armstrong, F. Daniel, Brouwers, Pim Y, Miller, Tracie L, Colin, Andrew A, Scott, Gwendolyn B, Shahzeidi, Shahriar, Willen, Elizabeth J, Asthana, Deshratn, Lipshultz, Steven E, Thompson, Bruce W, Shearer, William T

“…Abstract Youth infected with HIV at birth often have sleep disturbances, neurocognitive deficits, and abnormal psychosocial function which are associated with…”
Get full text

The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design by Thompson, Bruce W., Miller, Scott T., Rogers, Zora R., Rees, Renee C., Ware, Russell E., Waclawiw, Myron A., Iyer, Rathi V., Casella, James F., Luchtman-Jones, Lori, Rana, Sohail, Thornburg, Courtney D., Kalpatthi, Ram V., Barredo, Julio C., Brown, R. Clark, Sarnaik, Sharada, Howard, Thomas H., Luck, Lori, Wang, Winfred C.

“…Evidence of the laboratory benefits of hydroxyurea and its clinical efficacy in reducing acute vaso‐occlusive events in adults and children with sickle cell…”
Get full text

Two year prognosis of sarcoidosis: the ACCESS experience by Judson, Marc A, Baughman, Robert P, Thompson, Bruce W, Teirstein, Alvin S, Terrin, Michael L, Rossman, Milton D, Yeager, Jr, Henry, McLennan, Geoffrey, Bresnitz, Eddy A, DePalo, Louis, Hunninghake, Gary, Iannuzzi, Michael C, Johns, Carol J, Moller, David R, Newman, Lee S, Rabin, David L, Rose, Cecile, Rybicki, Benjamin A, Weinberger, Steven E, Knatterud, Genell L, Cherniak, Reuben

“…A cohort of 215 sarcoidosis patients from the ACCESS study underwent a clinical evaluation at study enrollment and two years later. Approximately 80% of…”
Get more information

HIV-associated lung infections and complications in the era of combination antiretroviral therapy by Crothers, Kristina, Thompson, Bruce W, Burkhardt, Kathryn, Morris, Alison, Flores, Sonia C, Diaz, Philip T, Chaisson, Richard E, Kirk, Gregory D, Rom, William N, Huang, Laurence

“…The spectrum of lung diseases associated with HIV is broad, and many infectious and noninfectious complications of HIV infection have been recognized. The…”
Get full text

A Circulating MicroRNA Signature Serves as a Diagnostic and Prognostic Indicator in Sarcoidosis by Ascoli, Christian, Huang, Yue, Schott, Cody, Turturice, Benjamin A, Metwally, Ahmed, Perkins, David L, Finn, Patricia W

“…MicroRNAs (miRNAs) act as post-transcriptional regulators of gene expression. In sarcoidosis, aberrant miRNA expression may enhance immune responses mounted…”
Get full text

Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial) by Bovill, Edwin G, Tracy, Russell P, Knatterud, Genell L, Stone, Peter H, Nasmith, Jim, Gore, Joel M, Thompson, Bruce W, Tofler, Geoffrey H, Kleiman, Neal S, Cannon, Christopher, Braunwald, Eugene

“…This study assesses the effects of invasive procedures, hemostatic and clinical variables, and doses of recombinant tissue plasminogen activator (t-PA) on…”
Get full text

A tutorial for modeling with WITNESS visual interactive simulator by Thompson, W. Bruce

Get full text

Genotoxicity Associated with Hydroxyurea Exposure in Infants with Sickle Cell Anemia: Results From the BABY-HUG Phase III Clinical Trial by McGann, Patrick T., Flanagan, Jonathan M, Howard, Thad A, Dertinger, Stephen D, He, Jin, Kulharya, Anita S, Thompson, Bruce W, Ware, Russell E.

“…Abstract 8▪▪This icon denotes a clinically relevant abstract The laboratory and clinical benefits of hydroxyurea therapy for children with sickle cell anemia…”
Get full text

Costs Associated with the Care of Very Young Children with Sickle Cell Anemia (SCA): Analysis from the BABY HUG Study by Wang, Winfred C., Oyeku, Suzette O., Luo, Zhaoyu, Boulet, Sheree L., Miller, Scott T., Fish, Billie, Thompson, Bruce W, Grosse, Scott

“…Abstract 171 The BABY HUG trial was a multi-center double-blinded randomized comparison of hydroxyurea (HU) versus placebo in infants (mean age 13.6 mo. at…”
Get full text

The Physiological and Clinical Effects of Interrupting a Treatment Regimen of Hydroxyurea in Young Children with Sickle Cell Anemia (SCA) by Thompson, Bruce W, Wang, Winfred C, Miller, Scott T., Rogers, Zora R., Ware, Russell E., Thornburg, Courtney D., Rana, Sohail R., Luchtman-Jones, Lori, Iyer, Rathi V., Casella, James F.

“…Abstract▪2134▪This icon denotes a clinically relevant abstract BABY HUG randomly assigned children with sickle cell anemia ages 9 to 18 months at entry to a…”
Get full text

TGF-β1 Variants in Chronic Beryllium Disease and Sarcoidosis by Jonth, Alexas C., Silveira, Lori, Fingerlin, Tasha E., Sato, Hiroe, Luby, Julie C., Welsh, Kenneth I., Rose, Cecile S., Newman, Lee S., du Bois, Roland M., Maier, Lisa A.

“…Abstract Evidence suggests a genetic predisposition to chronic beryllium disease (CBD) and sarcoidosis, which are clinically and pathologically similar…”
Get full text